Yahoo Search Busca da Web

Resultado da Busca

  1. 21 de fev. de 2021 · Colorectal cancer (CRC) is the third most common malignancy worldwide. Most patients with metastatic CRC develop liver or lung metastases, while a minority suffer from brain metastases. There is little information available regarding the presentation, treatment, and overall survival of brain metastases (BM) from CRC.

  2. 22 de jan. de 2021 · Conclusions: Brain metastases are rare in colorectal cancer but portend poor survival. Lung and bone metastases are found more frequently in these patients. Treatment with metastasectomy or multiagent chemotherapy is associated with improved overall survival.

    • Suleyman Yasin Goksu, Muhammad Shaalan Beg, Aravind Sanjeevaiah, Emrah Gumusgoz, David Hsieh, Muhamm...
    • 2021
  3. 4 de fev. de 2020 · 204. Background: More than 50% of colorectal cancer (CRC) patients will develop metastatic disease. Brain metastasis (BM) from colorectal cancer is uncommon (0.6-1.36%). This study aims to investigate the patient characteristics, treatment modalities and prognostic factors in this rare population.

    • Zhaohui Jin, William Breen, Rui Jin, Paul D. Brown, Joleen Marie Hubbard
    • 2020
  4. 7 de out. de 2022 · Article PDF Available. Brain metastasis from colorectal cancer: Treatment, survival, and prognosis. October 2022. Medicine 101 (40):e30273. DOI: 10.1097/MD.0000000000030273. License. CC...

  5. Our study supports the low incidence of brain metastasis in patients with colorectal cancer. A unique set of characteristics is identified to confer an increased risk of brain metastases. Keywords Brain metastasis · Predictors · Colorectal cancer · Incidence. Introduction.

  1. As pessoas também buscaram por